Phosphorylation of Bcl10 negatively regulates T-cell receptor-mediated NF-κB activation

Molecular and Cellular Biology

Volumn 27, Issue 14, 2007, Pages 5235-5245

  Zeng, Hu ^a,b   Di, Lie ^a,c   Fu, Guoping ^a   Chen, Yuhong ^a   Gao, Xiang ^b   Xu, Langlai ^c   Lin, Xin ^d   Wen, Renren ^a  

^a BLOOD RESEARCH INSTITUTE   (United States)

^b NANJING UNIVERSITY   (China)

^c NANJING AGRICULTURAL UNIVERSITY   (China)

^d UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; PROTEIN BCL 10; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; T LYMPHOCYTE ACTIVATION; UBIQUITINATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; DOWN-REGULATION; HUMANS; INTERLEUKIN-2; JURKAT CELLS; LYMPHOCYTE ACTIVATION; MICE; MODELS, BIOLOGICAL; NF-KAPPA B; PHOSPHORYLATION; RECEPTORS, ANTIGEN, T-CELL; SERINE; UBIQUITIN;

EID: 34447503930     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.01645-06     Document Type: Article

References (64)

1. Baldwin, A. S., Jr. 1996. The NF-κ B and I κ B proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649-683.
2. Cannons, J. L., L. J. Yu, B. Hill, L. A. Mijares, D. Dombroski, K. E. Nichols, A. Antonellis, G. A. Koretzky, K. Gardner, and P. L. Schwartzberg. 2004. SAP regulates T(H)2 differentiation and PKC-theta-mediated activation of NF-κB1. Immunity 21:693-706.
3. Cenciarelli, C., D. Hou, K. C. Hsu, B. L. Rellahan, D. L. Wiest, H. T. Smith, V. A. Fried, and A. M. Weissman. 1992. Activation-induced ubiquitination of the T cell antigen receptor. Science 257:795-797.
4. Chen, Y., X. Dai, A. L. Haas, R. Wen, and D. Wang. 2006. Proteasome-dependent down-regulation of activated Stat5A in the nucleus. Blood 108: 566-574.
5. Clements, J. L., N. J. Boerth, J. R. Lee, and G. A. Koretzky. 1999. Integration of T cell receptor-dependent signaling pathways by adapter proteins. Annu. Rev. Immunol. 17:89-108.
6. Costanzo, A., C. Guiet, and P. Vito. 1999. c-E10 is a caspase-recruiting domain-containing protein that interacts with components of death receptors signaling pathway and activates nuclear factor-κB. J. Biol. Chem. 274: 20127-20132.
7. Egawa, T., B. Albrecht, B. Favier, M. J. Sunshine, K. Mirchandani, W. O'Brien, M. Thome, and D. R. Littman. 2003. Requirement for CARMA1 in antigen receptor-induced NF-κ B activation and lymphocyte proliferation. Curr. Biol. 13:1252-1258.
8. Gaide, O., B. Favier, D. F. Legler, D. Bonnet, B. Brissoni, S. Valitutti, C. Bron, J. Tschopp, and M. Thome. 2002. CARMA1 is a critical lipid raft-associated regulator of TCR-induced NF-κ B activation. Nat. Immunol. 3:836-843.
9. Gaide, O., F. Martinon, O. Micheau, D. Bonnet, M. Thome, and J. Tschopp. 2001. Carma1, a CARD-containing binding partner of Bcl10, induces Bcl10 phosphorylation and NF-κB activation. FEBS Lett. 496:121-127.
10. Gerondakis, S., R. Grumont, I. Rourke, and M. Grossmann. 1998. The regulation and roles of Rel/NF-κ B transcription factors during lymphocyte activation. Curr. Opin. Immunol. 10:353-359.
11. Ghosh, S., and M. Karin. 2002. Missing pieces in the NF-κB puzzle. Cell 109(Suppl.):S81-S96.
12. Ghosh, S., M. J. May, and E. B. Kopp. 1998. NF-κ B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16:225-260.
13. Hara, H., C. Bakal, T. Wada, D. Bouchard, R. Rottapel, T. Saito, and J. M. Penninger. 2004. The molecular adapter Carmal controls entry of IκB kinase into the central immune synapse. J. Exp. Med. 200:1167-1177.
14. Hara, H., T. Wada, C. Bakal, I. Kozieradzki, S. Suzuki, N. Suzuki, M. Nghiem, E. K. Griffiths, C. Krawczyk, B. Bauer, F. D'Acquisto, S. Ghosh, W. C. Yeh, G. Baier, R. Rottapel, and J. M. Penninger. 2003. The MAGUK family protein CARD11 is essential for lymphocyte activation. Immunity 18:763-775.
15. Hawley, R. G., A. Z. Fong, B. F. Burns, and T. S. Hawley. 1992. Transplantable myeloproliferative disease induced in mice by an interleukin 6 retrovirus. J. Exp. Med. 176:1149-1163.
16. Heissmeyer, V., F. Macian, S.-H. Im, R. Varma, S. Feske, K. Venuprasad, H. Gu, Y.-C. Liu, M. L. Dustin, and A. Rao. 2004. Calcineurin imposes T cell unresponsiveness through targeted proteolysis of signaling proteins. Nat. Immunol. 5:255-265.
17. Horwitz, B. H., M. L. Scott, S. R. Cherry, R. T. Bronson, and D. Baltimore. 1997. Failure of lymphopoiesis after adoptive transfer of NF-κB-deficient fetal liver cells. Immunity 6:765-772.
18. Hu, S., M. Q. Du, S. M. Park, A. Alcivar, L. Qu, S. Gupta, J. Tang, M. Baens, H. Ye, T. H. Lee, P. Marynen, J. L. Riley, and X. Yang. 2006. cIAP2 is a ubiquitin protein ligase for BCL10 and is dysregulated in mucosa-associated lymphoid tissue lymphomas. J. Clin. Investig. 116:174-181.
19. Jun, J. E., L. E. Wilson, C. G. Vinuesa, S. Lesage, M. Blery, L. A. Miosge, M. C. Cook, E. M. Kucharska, H. Hara, J. M. Penninger, H. Domashenz, N. A. Hong, R. J. Glynne, K. A. Nelms, and C. C. Goodnow. 2003. Identifying the MAGUK protein Carma-1 as a central regulator of humoral immune responses and atopy by genome-wide mouse mutagenesis. Immunity 18:751-762.
20. Kane, L. P., and A. Weiss. 2003. The PI-3 kinase/Akt pathway and T cell activation: pleiotropic pathways downstream of PIP3. Immunol. Rev. 192: 7-20.
21. Karin, M., and Y. Ben-Neriah. 2000. Phosphorylation meets ubiquitination: the control of NF-[κ]B activity. Annu. Rev. Immunol. 18:621-663.
22. Koseki, T., N. Inohara, S. Chen, R. Carrio, J. Merino, M. O. Hottiger, G. J. Nabel, and G. Nunez. 1999. CIPER, a novel NF κB-activating protein containing a caspase recruitment domain with homology to herpesvirus-2 protein E10. J. Biol. Chem. 274:9955-9961.
23. Li, Q., and I. M. Verma. 2002. NF-κB regulation in the immune system. Nat. Rev. Immunol. 2:725-734.
24. Lin, X., and D. Wang. 2004. The roles of CARMA1, Bcl10, and MALT1 in antigen receptor signaling. Semin. Immunol. 16:429-435.
25. Lucas, P. C., M. Yonezumi, N. Inohara, L. M. McAllister-Lucas, M. E. Abazeed, F. F. Chen, S. Yamaoka, M. Seto, and G. Nunez. 2001. Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-κ B signaling pathway. J. Biol. Chem. 276:19012-19019.
26. Maes, B., A. Demunter, B. Peeters, and C. De Wolf-Peeters. 2002. BCL10 mutation does not represent an important pathogenic mechanism in gastric MALT-type lymphoma, and the presence of the API2-MLT fusion is associated with aberrant nuclear BCL10 expression. Blood 99:1398-1404.
27. Matsumoto, R., D. Wang, M. Blonska, H. Li, M. Kobayashi, B. Pappu, Y. Chen, D. Wang, and X. Lin. 2005. Phosphorylation of CARMA1 plays a critical role in T cell receptor-mediated NF-κB activation. Immunity 23:575-585.
28. McAllister-Lucas, L. M., N. Inohara, P. C. Lucas, J. Ruland, A. Benito, Q. Li, S. Chen, F. F. Chen, S. Yamaoka, I. M. Verma, T. W. Mak, and G. Nunez. 2001. Bimp1, a MAGUK family member linking protein kinase C activation to Bcl10-mediated NF-κB induction. J. Biol. Chem. 276:30589-30597.
29. Miura-Shimura, Y., L. Duan, N. L. Rao, A. L. Reddi, H. Shimura, R. Rottapel, B. J. Druker, A. Tsygankov, V. Band, and H. Band. 2003. Cbl-mediated ubiquitinylation and negative regulation of Vav. J. Biol. Chem. 278:38495-38504.
30. Newton, K., and V. M. Dixit. 2003. Mice lacking the CARD of CARMA1 exhibit defective B lymphocyte development and impaired proliferation of their B and T lymphocytes. Curr. Biol. 13:1247-1251.
31. Pantaleo, G., D. Olive, A. Poggi, T. Pozzan, L. Moretta, and A. Moretta. 1987. Antibody-induced modulation of the CD3AT cell receptor complex causes T cell refractoriness by inhibiting the early metabolic steps involved in T cell activation. J. Exp. Med. 166:619-624.
32. Rao, N., M. L. Lupher, Jr., S. Ota, K. A. Reedquist, B. J. Druker, and H. Band. 2000. The linker phosphorylation site Tyr292 mediates the negative regulatory effect of Cbl on ZAP-70 in T cells. J. Immunol. 164:4616- 4626.
33. Rao, N., S. Miyake, A. L. Reddi, P. Douillard, A. K. Ghosh, I. L. Dodge, P. Zhou, N. D. Fernandes, and H. Band. 2002. Negative regulation of Lck by Cbl ubiquitin ligase. Proc. Natl. Acad. Sci. USA 99:3794-3799.
34. Rudd, C. E. 1999. Adaptors and molecular scaffolds in immune cell signaling. Cell 96:5-8.
35. Ruefli-Brasse, A. A., D. M. French, and V. M. Dixit. 2003. Regulation of NF-κB-dependent lymphocyte activation and development by paracaspase. Science 302:1581-1584.
36. Ruland, J., G. S. Duncan, A. Elia, I. del Barco Barrantes, L. Nguyen, S. Plyte, D. G. Millar, D. Bouchard, A. Wakeham, P. S. Ohashi, and T. W. Mak. 2001. Bcl10 is a positive regulator of antigen receptor-induced activation of NF-κB and neural tube closure. Cell 104:33-42.
37. Ruland, J., G. S. Duncan, A. Wakeham, and T. W. Mak. 2003. Differential requirement for Malt1 in T and B cell antigen receptor signaling. Immunity 19:749-758.
38. Saijo, K., I. Mecklenbrauker, A. Santana, M. Leitger, C. Schmedt, and A. Tarakhovsky. 2002. Protein kinase C beta controls nuclear factor κB activation in B cells through selective regulation of the IκB kinase alpha. J. Exp. Med. 195:1647-1652.
39. San Jose, E., A. Borroto, F. Niedergang, A. Alcover, and B. Alarcon. 2000. Triggering the TCR complex causes the downregulation of nonengaged receptors by a signal transduction-dependent mechanism. Immunity 12:161-170.
40. Schaefer, B. C., J. W. Kappler, A. Kupfer, and P. Marrack. 2004. Complex and dynamic redistribution of NF-κB signaling intermediates in response to T cell receptor stimulation. Proc. Natl. Acad. Sci. USA 101:1004-1009.
41. Scharschmidt, E., E. Wegener, V. Heissmeyer, A. Rao, and D. Krappmann. 2004. Degradation of Bcl10 induced by T-cell activation negatively regulates NF-κB signaling. Mol. Cell. Biol. 24:3860-3873.
42. Schonrich, G., U. Kalinke, F. Momburg, M. Malissen, A. M. Schmitt-Verhulst, B. Malissen, G. J. Hammerling, and B. Arnold. 1991. Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction. Cell 65:293-304.
43. Siebenlist, U., K. Brown, and E. Claudio. 2005. Control of lymphocyte development by nuclear factor-κB. Nat. Rev. Immunol. 5:435-445.
44. Sommer, K., B. Guo, J. L. Pomerantz, A. D. Bandaranayake, M. E. Moreno-Garcia, Y. L. Ovechkina, and D. J. Rawlings. 2005. Phosphorylation of the CARMA1 linker controls NF-κB activation. Immunity 23:561-574.
45. Srinivasula, S. M., M. Ahmad, J. H. Lin, J. L. Poyet, T. Fernandes-Alnemri, P. N. Tsichlis, and E. S. Alnemri. 1999. CLAP, a novel caspase recruitment domain-containing protein in the tumor necrosis factor receptor pathway, regulates NF-κB activation and apoptosis. J. Biol. Chem. 274:17946-17954.
46. Su, T. T., B. Guo, Y. Kawakami, K. Sommer, K. Chae, L. A. Humphries, R. M. Kato, S. Kang, L. Patrone, R. Wall, M. Teitell, M. Leitges, T. Kawakami, and D. J. Rawlings. 2002. PKC-beta controls IκB kinase lipid raft recruitment and activation in response to BCR signaling. Nat. Immunol. 3:780-786.
47. Sun, Z., C. W. Arendt, W. Ellmeier, E. M. Schaeffer, M. J. Sunshine, L. Gandhi, J. Annes, D. Petrzilka, A. Kupfer, P. L. Schwartzberg, and D. R. Littman. 2000. PKC-theta is required for TCR-induced NF-κB activation in mature but not immature T lymphocytes. Nature 404:402-407.
48. Thome, M. 2004. CARMA1, BCL-10 and MALT1 in lymphocyte development and activation. Nat. Rev. Immunol. 4:348-359.
49. Thome, M., F. Martinon, K. Hofmann, V. Rubio, V. Steiner, P. Schneider, C. Mattmann, and J. Tschopp. 1999. Equine herpesvirus-2 E10 gene product, but not its cellular homologue, activates NF-κB transcription factor and c-Jun N-terminal kinase. J. Biol. Chem. 274:9962-9968.
50. Uren, A. G., K. O'Rourke, L. A. Aravind, M. T. Pisabarro, S. Seshagiri, E. V. Koonin, and V. M. Dixit. 2000. Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma. Mol. Cell 6:961-967.
51. Valitutti, S., S. Muller, M. Salio, and A. Lanzavecchia. 1997. Degradation of T cell receptor (TCR)-CD3-zeta complexes after antigenic stimulation. J. Exp. Med. 185:1859-1864.
52. Viola, A., and A. Lanzavecchia. 1996. T cell activation determined by T cell receptor number and tunable thresholds. Science 273:104-106.
53. Wang, D., R. Matsumoto, Y. You, T. Che, X. Y. Lin, S. L. Gaffen, and X. Lin. 2004. CD3/CD28 costimulation-induced NF-κB activation is mediated by recruitment of protein kinase C-theta, Bcl10, and IκB kinase beta to the immunological synapse through CARMA1. Mol. Cell. Biol. 24:164-171.
54. Wang, D., Y. You, S. M. Case, L. M. McAllister-Lucas, L. Wang, P. S. DiStefano, G. Nunez, J. Bertin, and X. Lin. 2002. A requirement for CARMA1 in TCR-induced NF-κ B activation. Nat. Immunol. 3:830-835.
55. Wegener, E., A. Oeckinghaus, N. Papadopoulou, L. Lavitas, M. Schmidt-Supprian, U. Ferch, T. W. Mak, J. Ruland, V. Heissmeyer, and D. Krappmann. 2006. Essential Role for IκB kinase beta in remodeling Carma1-Bcl10-Malt1 complexes upon T cell activation. Mol. Cell 23:13-23.
56. Wen, R., Y. Chen, J. Schuman, G. Fu, S. Yang, W. Zhang, D. K. Newman, and D. Wang. 2004. An important role of phospholipase Cγ1 in pre-B-cell development and allelic exclusion. EMBO J. 23:4007-4017.
57. Wen, R., Y. Chen, L. Xue, J. Schuman, S. Yang, S. W. Morris, and D. Wang. 2003. Phospholipase Cγ2 provides survival signals via Bcl2 and A1 in different subpopulations of B cells. J. Biol. Chem. 278:43654- 43662.
58. Wen, R., D. Wang, C. McKay, K. D. Bunting, J. C. Marine, E. F. Vanin, G. P. Zambetti, S. J. Korsmeyer, J. N. Ihle, and J. L. Cleveland. 2001. Jak3 selectively regulates Bax and Bcl-2 expression to promote T-cell development. Mol. Cell. Biol. 21:678-689.
59. Willis, T. G., D. M. Jadayel, M. Q. Du, H. Peng, A. R. Perry, M. Abdul-Rauf, H. Price, L. Karran, O. Majekodunmi, I. Wlodarska, L. Pan, T. Crook, R. Hamoudi, P. G. Isaacson, and M. J. Dyer. 1999. Bcl10 is involved in t(1; 14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell 96:35-45.
60. Xue, L., S. W. Morris, C. Orihuela, E. Tuomanen, X. Cui, R. Wen, and D. Wang. 2003. Defective development and function of Bcl10-deficient follicular, marginal zone and B1 B cells. Nat. Immunol. 4:857-865.
61. Yan, M., J. Lee, S. Schilbach, A. Goddard, and V. Dixit. 1999. mE10, a novel caspase recruitment domain-containing proapoptotic molecule. J. Biol. Chem. 274:10287-10292.
62. Ye, H., A. Dogan, L. Karran, T. G. Willis, L. Chen, I. Wlodarska, M. J. Dyer, P. G. Isaacson, and M. Q. Du. 2000. BCL10 expression in normal and neoplastic lymphoid tissue. Nuclear localization in MALT lymphoma. Am. J. Pathol. 157:1147-1154.
63. Ye, H., H. Liu, M. Raderer, A. Chott, A. Ruskone-Fourmestraux, A. Wotherspoon, M. J. Dyer, S. S. Chuang, A. Dogan, P. G. Isaacson, and M. Q. Du. 2003. High incidence of t(11;18)(q21;q21) in Helicobacter pylori-negative gastric MALT lymphoma. Blood 101:2547-2550.
64. Zhang, Q., R. Siebert, M. Yan, B. Hinzmann, X. Cui, L. Xue, K. M. Rakestraw, C. W. Naeve, G. Beckmann, D. D. Weisenburger, W. G. Sanger, H. Nowotny, M. Vesely, E. Callet-Bauchu, G. Salles, V. M. Dixit, A. Rosenthal, B. Schlegelberger, and S. W. Morris. 1999. Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32). Nat. Genet. 22:63-68.